Besides that, more clinical studies should be conducted to verify the efficacy of HDAC inhibitors as a potential therapeutic strategy in mitigating synaptic microtubule damage and memory impairment in AD patients. The gene discussed is HDAC9; the disease is Alzheimer disease.